, Incyte Corp (INCY) Covered Calls

, Incyte Corp covered calls Incyte Corporation is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

You can sell covered calls on , Incyte Corp to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for INCY (prices last updated Wed 4:16 PM ET):

, Incyte Corp (INCY) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
83.74 -0.34 75.00 84.98 1.1M 165 18B
Covered Calls For , Incyte Corp (INCY)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Mar 15 82.5 3.20 81.78 0.9% 13.7%
Apr 18 82.5 4.60 80.38 2.6% 16.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Incyte Corp. is a biopharmaceutical company. It focuses on the discovery, development and commercialization of proprietary small molecule drugs to treat serious unmet medical needs. The company's product, Jakafi (ruxolitinib), a JAK1 and JAK2 inhibitor, is currently approved in the U.S. for the treatment of intermediate or high-risk myelofibrosis and is in development as a potential treatment for other cancers. Incyte was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.